COVID19 DREAM Study [COVID-19]
Research type
Research Study
Full title
Covid19 Dried bloodspot Antibody Measurement (DREAM) study
IRAS ID
284129
Contact name
Stephen Jolles
Contact email
Sponsor organisation
University Hospital of Wales
Duration of Study in the UK
2 years, 0 months, 0 days
Research summary
This research study will look at a new way of testing for antibodies to SARSCoV2 the virus which causes COVID19 using dried blood spots (DBS). Dried blood spots are used at the moment to test for nine different diseases on a drop of blood taken from a heel prick in newborn children. The drop of blood is spotted onto filter paper and is then sent in the post to the laboratory for testing. This avoids needing someone to take blood using a needle and syringe. This study will look to see if this simple technique can be used to test for COVID19 and compare results of the dried blood spot to tests which use a normal blood test. If the blood spot method works it will mean less staff are needed to take blood and as the test can be done using a finger prick (like a diabetic test for blood sugar) travel to hospital for a test are not needed.
REC name
South West - Cornwall & Plymouth Research Ethics Committee
REC reference
20/SW/0104
Date of REC Opinion
3 Jul 2020
REC opinion
Favourable Opinion